Rifabutin-based Helicobacter pylori eradication 'rescue therapy'

被引:65
作者
Canducci, F [1 ]
Ojetti, V [1 ]
Pola, P [1 ]
Gasbarrini, G [1 ]
Gasbarrini, A [1 ]
机构
[1] Catholic Univ, Gemelli Hosp, Dept Internal Med, Rome, Italy
关键词
D O I
10.1046/j.1365-2036.2001.00909.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:143 / 143
页数:1
相关论文
共 4 条
[1]   Severe neutropenia caused by recommended prophylactic doses of rifabutin [J].
Apseloff, G ;
Foulds, G ;
LaBoyGoral, L ;
Kraut, E ;
Vincent, J .
LANCET, 1996, 348 (9028) :685-685
[2]   ADVERSE EVENTS ASSOCIATED WITH HIGH-DOSE RIFABUTIN IN MACROLIDE-CONTAINING REGIMENS FOR THE TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX LUNG-DISEASE [J].
GRIFFITH, DE ;
BROWN, BA ;
GIRARD, WM ;
WALLACE, RJ .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) :594-598
[3]   Metabolism of rifabutin in human enterocyte and liver microsomes: Kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents [J].
Iatsimirskaia, E ;
Tulebaev, S ;
Storozhuk, E ;
Utkin, I ;
Smith, D ;
Gerber, N ;
Koudriakova, T .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (05) :554-562
[4]  
Perri F, 2000, ALIMENT PHARM THER, V14, P311